Fiche publication
Date publication
novembre 2025
Journal
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Auteurs
Membres identifiés du Cancéropôle Est :
Dr PINEL Sophie
Tous les auteurs :
Bayart É, Benderitter M, Boussin F, Balosso J, Deutsch É, Cohen Jonathan-Moyal É, Lacornerie T, Pinel S, Prezado Y, Robert C, Supiot S, Delpon G, Bourgier C
Lien Pubmed
Résumé
The RadioTransNet program, led by the Société française de radiothérapie oncologique (SFRO, the French society for radiation oncology) in association with the Société française de physique médicale (SFPM, the French society of medical physics), certified by the Institut du cancer (INCa, the French national cancer institute), was created at the end of 2018. The aim is to create a coherent, national, and multidisciplinary structure for preclinical and translational research in oncological radiotherapy by identifying research priorities. Its activities are coordinated by a scientific council, composed of radiation oncologists-therapists, medical physicists and academic radiobiologists researchers, and organized around four major axes which are: the definition of target volumes, the interaction of ionizing radiation with tissues, combined treatments and modern approaches to dose calculation. These four major axes are associated with different objectives concerning basic radiobiology, the studies of implementation of new drugs in preclinical settings, the contribution of imaging and new tracers, research in medical physics, by integrating a cross-cutting dimension of medical oncology and cost/effectiveness considerations. The selected themes form the basis for the projects studied and developed, taking into account the complementary skills of all the partner platforms involved in the network. Orientation proposals based on the priorities selected by the scientific council are submitted to INCa for the opening of dedicated calls to finance the human and technical resources necessary to conduct, under the best conditions, preclinical and translational research in radiotherapy.
Mots clés
Calcul de dose, Cancer, Combined treatments, Dose calculation, Healthy tissues, Medical physics, Physique médicale, Preclinical research, Radiobiologie, Radiobiology, Radiotherapy, Radiothérapie, Recherche pré-clinique, Recommandations, Recommendations, SFRO, Société française de radiothérapie oncologique, Target volumes, Tissus sains, Traitements combinés, Volumes cibles
Référence
Cancer Radiother. 2025 11 24;29(7-8):104764
